Showing results (1251-1260 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1994
Phase I study of mitonafide with a 3-day administration schedule: early interruption due to severe central nervous system toxicityE Díaz-Rubio, M Martín, J M López-Vega, et al.Investigational New Drugs|January 1, 1994
Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244)J D Jonkman-de Vries, M J de Graaff-Teulen, R E Henrar, et al.Investigational New Drugs|January 1, 1994
Phase II study of elsamitrucin in non-small cell lung cancerG Goss, F Letendre, D Stewart, et al.Investigational New Drugs|January 1, 1994
Hepatoma/merbarone. A Southwest Oncology Group studyE A Poplin, C M Tangen, W H Harvey, et al.Investigational New Drugs|January 1, 1994
Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group studyJ P Kuebler, J Benedetti, D E Schuller, et al.Investigational New Drugs|January 1, 1994
Multidrug resistance in cancer chemotherapyN H Patel, M L RothenbergInvestigational New Drugs|January 1, 1994
Phase I study of combined alpha interferon, alpha difluoromethylornithine (DFMO), and doxorubicin in advanced malignancyV Ganju, J H Edmonson, J C BucknerInvestigational New Drugs|January 1, 1994
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreasE S Casper, M R Green, D P Kelsen, et al.Investigational New Drugs|January 1, 1994
Phase II study of carboplatin (CBDCA) in refractory multiple myeloma. A Southwest Oncology Group studyB Barlogie, J Crowley, S E Salmon, et al.Investigational New Drugs|January 1, 1994
Phase II trial of menogaril in metastatic adenocarcinoma of the prostate. A Southwest Oncology Group studyS A Taylor, B A Blumenstein, R L Stephens, et al.Pageof 372